Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Merck Serono launches Kuvan in Europe

April 24, 2009 Sales and Marketing Kuvan, Merck Serono, PKU

Kuvan, the first treatment for two rare neurological disorders, has been launched in the UK, France and Germany.Merck Serono’s drug …
News

Spiriva leads charge for Boehringer

April 23, 2009 Sales and Marketing Boehringer, COPD

News

Pharma-NHS joint working

April 22, 2009 Research and Development, Sales and Marketing ABPI, doctors, industry relations

An underlying principle for joint working between the NHS and the pharmaceutical industry is that it brings benefits to patients. …
Feature

GSK launches Alli in Europe

April 22, 2009 Sales and Marketing Alli, Europe, GSK

GSK has launched Alli, making it the first clinically proven over-the-counter weight loss aid to be available in pharmacies across …
News

Little benefit to pharma from G20 initiatives

April 22, 2009 Research and Development, Sales and Marketing Datamonitor, strategy

Any positive effect on the pharmaceutical industry derived from the G20 summit and European Union summit will be indirect and …
News

AZ shuns mega-mergers but still open to smaller deals

April 21, 2009 Research and Development, Sales and Marketing AZ

AstraZeneca will not follow this year's emerging pharma trend towards mega-mergers and may instead look to smaller-scale deals, according to …
News

GSK buys Stiefel for $3.6bn

April 20, 2009 Research and Development, Sales and Marketing GSK, MA

GSK has acquired Stiefel, the world's largest independent dermatology company, in a deal valued up to $3.6 billion. The move …
News

GSK and Pfizer to create HIV joint venture company

April 16, 2009 Research and Development, Sales and Marketing GSK, HIV, Pfizer

The world's two biggest pharma companies are to join forces to develop and market new treatments for HIV.GlaxoSmithKline is a …
News

Merck acquires rights to atrial fibrillation candidate

April 16, 2009 Research and Development, Sales and Marketing Merck, cv

Merck has signed an agreement with Vancouver-based Cardiome Pharma to develop its new treatment for atrial fibrillation vernakalant.Merck will pay …
News

Avastin helps Roche outpace the market again

April 16, 2009 Sales and Marketing Roche

Strong sales growth across all its business divisions, including prescription medicines has helped Roche outpace the market again in the …
News

Simponi approved in Canada

April 16, 2009 Research and Development, Sales and Marketing J&J, JJ, Simponi

Johnson & Johnson's monoclonal antibody Simponi has been given regulatory approval in Canada.Simponi (golimumab) has been given the green light …
News

Lilly’s ex-marketing chief joins Innovex

April 14, 2009 Business Services, Medical Communications, Sales and Marketing Innovex

Richard Pilnik, Lilly's head of marketing is to join contract sales organisation Innovex to serve as its president.Pilnik has 25 …
News

Committee approves limited use of Seroquel in depression

April 9, 2009 Research and Development, Sales and Marketing AZ, Seroquel, US

An FDA advisory committee has concluded that safety concerns mean that Seroquel XR should not be used to treat anxiety, …
News

Efient launched in the UK

April 9, 2009 Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo's blood-thinning drug Efient has been launched in the UK for heart attack patients, taking on blockbuster …
News

Frustration over pharma’s digital marketing impasse

April 8, 2009 Sales and Marketing ABPI, digi

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026